Dilon Diagnostics is a market leader for compact gamma cameras that support breast-specific gamma imaging/molecular breast imaging (BSGI/MBI) studies. Dilon optimizes the clinical results of BSGI/MBI, a procedure that sees lesions independent of tissue density and provides a functional imaging complement to the anatomical imaging of mammography. BSGI/MBI is particularly useful for patients with equivocal mammograms, dense breast tissue and for help with determining the extent of disease.

With camera installations worldwide, Dilon is now expanding its product range in women’s imaging to include the PenRad mammography information system (MIS), and Volpara, a quantitative breast density-assessment tool that converts the qualitative breast X-ray image into quantitative data. Breast tissue density has not only been tied to an increased risk of breast cancer, it also decreases the sensitivity of the mammogram and thereby may impact early detection. Volpara is designed to assist radiologists by assessing a woman’s breast density objectively and automatically, and facilitates breast centers’ compliance with new legislation and notification guidelines. PenRad automatically integrates the information from Volpara and BSGI/MBI into the routine MIS workflow.

PenRad has been pioneering the technologic advancement of MIS for 15 years, increasing professional productivity, reducing costs, and enhancing patient care.

CEO of Dilon Diagnostics, Robert G. Moussa, said, “Dilon’s expanded suite of PenRad MIS products align well with our global strategy of providing diagnostic solutions with the most sophisticated technological platforms. Our vision is to provide patients and physicians around the world with superior, cost-effective, and healthcare solutions that provide the greatest opportunity for early diagnosis and intervention for breast cancer.”

PenRad’s range of products provides a complete solution to enhance workflow, quality, and revenue in image and information management. Designed flexible and for easy integration, PenRad products include a Web-based, multimodality workstation, computer-aided visualization, and analysis for magnetic resonance imaging (MRI) and computer-aided detection (CAD) for ultrasound, and information systems for fast and effective interpretation, reporting, tracking, and management of clinical data. Whether integrating with existing infrastructure or providing a complete solution, PenRad partners with customers to optimize workflow.

Dilon Diagnostics, a brand of Dilon Technologies, Inc., is bringing innovative medical imaging products to the global medical marketplace. Dilon’s cornerstone product, the Dilon 6800, is a digital high-resolution, compact gamma camera optimized to perform BSGI, a molecular breast imaging procedure, which images the metabolic activity of breast lesions through radiotracer uptake, indicating the presence or absence of a cancer.

Related Links:
Dilon
PenRad